LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Vivos Therapeutics (NASDAQ: VVOS)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ VVOS Vivos Therapeutics
Huntsman Ronald Kirk / director, officer: Chief Executive Officer
11/26/2024
Buy
$2.64
315,421
$833K
364,755
NASDAQ VVOS Vivos Therapeutics
Amman Bradford K. / officer: Chief Financial Officer
11/26/2024
Buy
$2.64
149,533
$395K
180,533

COPYRIGHT ©2023 HEALTH STOCKS HUB